For in vitro diagnostic use. Others Elecsys ProGRP IVD Elecsys® ProGRP CPS_000502 06505961190 proGRP Elecsys cobas e 100 Elecsys ProGRP 04015630933310 Reagents, kits 100 tests cobas e 411/601/602 true 09007636190 proGRP Elecsys cobas e 100 V2 Elecsys ProGRP 07613336171622 Reagents, kits 100 tests cobas e 411/601/602 true 07027702190 proGRP Elecsys E2G 100 Elecsys ProGRP 04015630940486 Reagents, kits 100 tests cobas e 402/801 true 09007695190 proGRP Elecsys E2G 100 V2 Elecsys ProGRP 07613336199435 Reagents, kits 100 tests cobas e 402/801 true ms_06505961190 Elecsys ProGRP en 7 FF000000047C6C0E FF0000000011FF0E 06505961190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the quantitative determination of ProGRP in human plasma and serum. The assay is used to aid in the differential diagnosis in lung cancerLREFKorse CM, Holdenrieder S, Zhi X-y, et al. Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China. Clin Chim Acta 2015;438:388-395. and in the management of patients with small cell lung cancer in conjunction with other clinical methods. The results must be interpreted in conjunction with other methods in accordance with standard clinical management guidelines.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 09007636500 Elecsys ProGRP en 2 FF000000047C700E FF0000000415EB0E 09007636190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the quantitative determination of ProGRP in human plasma and serum. The assay is used to aid in the differential diagnosis in lung cancerLREFKorse CM, Holdenrieder S, Zhi X-y, et al. Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China. Clin Chim Acta 2015;438:388-395. and in the management of patients with small cell lung cancer in conjunction with other clinical methods. The results must be interpreted in conjunction with other methods in accordance with standard clinical management guidelines.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07027702500 Elecsys ProGRP en 4 FF000000047C6E0E FF00000001A8C90E 07027702190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the quantitative determination of ProGRP in human plasma and serum. The assay is used to aid in the differential diagnosis in lung cancerLREFKorse CM, Holdenrieder S, Zhi X-y, et al. Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China. Clin Chim Acta 2015;438:388-395. and in the management of patients with small cell lung cancer in conjunction with other clinical methods. The results must be interpreted in conjunction with other methods in accordance with standard clinical management guidelines.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 09007695500 Elecsys ProGRP en 4 FF00000004A4D30E FF0000000432CC0E 09007695190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the quantitative determination of ProGRP in human plasma and serum. The assay is used to aid in the differential diagnosis in lung cancerLREFKorse CM, Holdenrieder S, Zhi X-y, et al. Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China. Clin Chim Acta 2015;438:388-395. and in the management of patients with small cell lung cancer in conjunction with other clinical methods. The results must be interpreted in conjunction with other methods in accordance with standard clinical management guidelines.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en